GlassScriptPhysician profile
Judy M Lim
NPI 1083667208
$11,712.00
in general payments reported to CMS, 2019-2025
47 companies · $1,583 in 2025
The $1,583 reported for 2025 was more than what 93% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,779 · 2020: $774 · 2021: $1,293 · 2022: $2,392 · 2023: $2,027 · 2024: $1,864 · 2025: $1,583.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,442 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,441.69 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,005.03 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Glaxosmithkline, LLC. | $1,555.75 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Abbvie INC. | $1,062.68 | 2021-2025 | |
| Lilly USA, LLC | $1,051.32 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $832.32 | 2019-2025 | Ozempic, Rybelsus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $747.73 | 2019-2025 | Jardiance, Ofev |
| Pfizer INC. | $588.47 | 2019-2025 | |
| Abbott Laboratories | $373.18 | 2022-2025 | Freestyle Libre 3 |
| Sanofi-Aventis U.S. LLC | $312.60 | 2019-2023 | |
| Amgen INC. | $293.46 | 2019-2025 | Repatha, Otezla, Evenity |
| Janssen Pharmaceuticals, INC | $289.68 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $257.51 | 2021-2024 | |
| Merck Sharp & Dohme LLC | $241.76 | 2019-2022 | |
| Astellas Pharma US INC | $223.33 | 2019-2025 | Veozah |
| Otsuka America Pharmaceutical, INC. | $190.85 | 2021-2025 | Rexulti |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Judy Lim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.